Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Serum High Sensitivity C-Reactive Protein Associated With Pre-Diabetes

By LabMedica International staff writers
Posted on 29 Dec 2021
Individuals with pre-diabetes are at a higher risk for progression to diabetes and are also known to be associated with an increased risk of cardiovascular disease. More...
Also, pre-diabetes is known to be associated with obesity and an abnormal lipid profile.

C-reactive protein (CRP) is an acute-phase protein that is increased in infections, inflammatory conditions, and even cancers. Low-grade inflammation is said to be associated with pre-diabetes and high sensitivity CRP (hsCRP) is an indicator of inflammation.

Clinical Scientists at the Jawaharlal Nehru Medical College (Wardha, India) carried out a cross-sectional study from October 2018 to August 2020 to determine whether hsCRP can be used as a biomarker in the early diagnosis of pre-diabetes in a rural population. A total of 200 participants, including 100 diabetics and 100 controls who were age- and gender-matched, were enrolled. Blood investigations included blood glucose levels, lipid profile, and high sensitivity CRP. The hsCRP levels were tested by an ultrasensitive CRP kit, and were measured by the spectrophotometric method using an enzyme-linked immunosorbent assay (ELISA) Turbichem-Hs-CRP kit, (Genuine Biosystem, Chennai, India). The test was based on the two-site sandwich enzyme immunoassay principle.

The investigators reported that the mean value of high sensitivity CRP for cases was 2.17 ± 0.72 mg/L. The mean value of high sensitivity CRP for controls was 0.66 ± 0.22 mg/L and therefore high sensitivity CRP for diabetics was significantly higher than controls. High sensitivity CRP was significantly and positively correlated to age, body mass index (BMI), total cholesterol, low-density lipoprotein, cholesterol, and waist-hip ratio.

The authors concluded that Hs-CRP, which is a marker of inflammation, was also found to be correlated with abnormal lipid profiles and oral glucose tolerance tests. The Hs-CRP can be used as an early predictor of inflammation in pre-diabetes and can be a marker of underlying abnormal sugar levels and lipid profile in pre-diabetics unaware of their health status. The study was published on October 28, 2021 in the journal Cureus.

Related Links:
Jawaharlal Nehru Medical College
Genuine Biosystem



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.